Twitter LinkedIn YouTube iTune Podcast Google Podcasts Spotify

MedX Health Corp. TSXV: MDX

InvestorIntel Features on MedX Health Corp.

Skin cancer technology company wins #1 for audience favorite at the ii6 Summit

Letter from the Publisher: We recently hosted the ii6 Summit Series – V01 at the King Edward in Toronto and had […]

Druhan on MedX’s skin cancer diagnosis technology getting closer to being launched in Brazil

“MedX solves a really unique problem and that is access to a dermatologist. In Canada, there are 565 dermatologists serving 37 […]

How MedX technology can have your potential skin cancer diagnosed in 72 hours

“MedX is a company that has a visual technology that allows image capture not only on top of the skin […]

Company Overview

TeamWebsite

MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin cancer with its DermSecure™ telemedicine platform, utilizing its SIAscopy technology. SIAscopy is also imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA (US), ARTG and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union and Turkey. MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. www.medxhealth.com.

News Releases

View All News

Twitter LinkedIn YouTube Amazon Alexa iTune Podcast Google Podcasts Spotify